Common Shares, no par value per share

EDESA BIOTECH, INC.

100 Spy Court, Markham, A6, L3R 5H6

As of the date hereof, Pardeep Nijhawan may be deemed to be the beneficial owner of an aggregate of 2,613,492 Common Shares, comprised of: (i) sole voting and dispositive power of 1,331,090 Common Shares, comprised of: (a) 262,094 Common Shares, (b) 491,288 Common Shares underlying vested restricted share units or restricted share units that will vest within 60 days of August 25, 2026, (c) 56,875 Common Shares underlying vested share options or underlying share options that will vest within 60 days of August 25, 2026 and (d) 520,833 Common Shares underlying Series B-1 Preferred Shares that are beneficially owned and deemed outstanding with respect to this Reporting Person; and (ii) shared voting and dispositive power of 1,282,402 Common Shares, comprised of: (a) 402,702 Common Shares, an additional 326,560 Common Shares underlying vested warrants and 435,414 Common Shares underlying Series A-1 Preferred Shares that are deemed outstanding held by Pardeep Nijhawan Medicine Professional Corporation, (b) 32,013 Common Shares held by The Digestive Health Clinic Inc., (c) 53,104 Common Shares held by 1968160 Ontario Inc., and (d) 32,609 Common Shares held by The New Nijhawan Family Trust 2015. Pardeep Nijhawan's holdings exclude Common Shares underlying restricted share units held by this Reporting Person that will not vest within 60 days of August 25, 2026 and Common Shares underlying share options held by this Reporting Person that will not vest within 60 days of August 25, 2026. Pardeep Nijhawan's holdings represent an aggregate of approximately 16.31% of the Issuer's outstanding Common Shares (based on a total of 14,193,356 Common Shares of the Issuer outstanding as of August 25, 2026, 56,875 Common Shares underlying vested share options or underlying share options that will vest within 60 days of August 25, 2026, 491,288 Common Shares underlying vested restricted share units or restricted share units that will vest within 60 days of August 25, 2026, 326,560 Common Shares underlying vested warrants, 435,414 Common Shares underlying Series A-1 Preferred Shares and 520,833 Common Shares underlying Series B-1 Preferred Shares that are beneficially owned and deemed outstanding with respect to this Reporting Person). As of the date hereof, Pardeep Nijhawan Medicine Professional Corporation may be deemed to be the beneficial owner, with shared voting and dispositive power, of an aggregate of 1,164,676 Common Shares, comprised of: (i) 402,702 Common Shares, (ii) 326,560 Common Shares underlying vested warrants and (iii) 435,414 Common Shares underlying Series A-1 Preferred Shares that are deemed outstanding with respect to this Reporting Person. Pardeep Nijhawan Medicine Professional Corporation's holdings represent an aggregate of approximately 7.8% of the Issuer's outstanding Common Shares (based on a total of 14,193,356 Common Shares of the Issuer outstanding as of August 25, 2026, 326,560 Common Shares underlying vested warrants and 435,414 Common Shares underlying Series A-1 Preferred Shares that are deemed outstanding with respect to this Reporting Person). As of the date hereof, The Digestive Health Clinic Inc. may be deemed to be the beneficial owner, with shared voting and dispositive power, of 32,013 Common Shares, representing an aggregate of approximately 0.2% of the Issuer's outstanding Common Shares (based on a total of 14,193,356 Common Shares of the Issuer outstanding as of August 25, 2026). As of the date hereof, 1968160 Ontario Inc. may be deemed to be the beneficial owner, with shared voting and dispositive power, of 53,104 Common Shares, representing an aggregate of approximately 0.4% of the Issuer's outstanding Common Shares (based on a total of 14,193,356 Common Shares of the Issuer outstanding as of August 25, 2026). As of the date hereof, The New Nijhawan Family Trust 2015 may be deemed to be the beneficial owner, with shared voting and dispositive power, of 32,609 Common Shares, representing an aggregate of approximately 0.2% of the Issuer's outstanding Common Shares (based on a total of 14,193,356 Common Shares of the Issuer outstanding as of August 25, 2026).

The information contained in Item 5(a) of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5(b).

Except as set forth in this Schedule 13D, the Reporting Persons have not effected any transactions with respect to the Common Shares of the Issuer during the past 60 days.